Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-195281
Filing Date
2012-04-30
Accepted
2012-04-30 14:20:26
Documents
5
Period of Report
2012-06-15
Effectiveness Date
2012-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d336720ddef14a.htm DEF 14A 369392
2 GRAPHIC g336720g01c85.jpg GRAPHIC 9088
3 GRAPHIC g336720g22s07.jpg GRAPHIC 246872
4 GRAPHIC g336720g37q70.jpg GRAPHIC 8663
5 GRAPHIC g336720g52k26.jpg GRAPHIC 7343
  Complete submission text file 0001193125-12-195281.txt   746029
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 12794025
SIC: 2834 Pharmaceutical Preparations